If you need more lookups,
subscriptions start at $34 USD/month.
Eric Verschuren Location
Netherlands
Eric Verschuren Work
Clinical Medical Manager @ (February 2024 - Present)
Clinical Research Associate @ (January 2023 - January 2024)
Scientist Drug Discovery @ (March 2022 - December 2022)
Scientist Drug Discovery @ (May 2020 - March 2022)
Technical Support Specialist @ (January 2020 - March 2020)
PhD candidate in Kidney Physiology @ (February 2016 - December 2019)
Research Intern Kidney Physiology @ (September 2015 - January 2016)
Research Intern Tumor Immunology @ (March 2015 - September 2015)
Research Intern Molecular Biology @ (May 2014 - July 2014)
Research Intern Pathology and Human Genetics @ (August 2012 - June 2013)
Research Intern Pathology @ (January 2012 - June 2012)
Eric Verschuren Education
Biobusiness Summerschool 2019-2019
Radboud University 2016-2019
Dutch Kidney Foundation Winterschool 2017-2017
Wageningen University & Research 2013-2015
HAN University of Applied Sciences 2010-2013
Eric Verschuren Skills
Molecular Cloning
Immunohistochemistry
qPCR
Protein Purification
Western Blotting
Cell Culture
SDS-PAGE
RNA isolation
Nanodrop
Transfection
Gel Electrophoresis
DNA extraction
Spectroscopy
Histology
Immunocytochemistry
Immunofluorescence
PCR
Cytology
viral cell transduction
Primer Design
RT-PCR
Southern Blot
Chromatography
Biotechnology
Research
FACS
ELISA
Confocal Microscopy
Molecular Biology
Biochemistry
Immunology
Cell Biology
siRNA
Microfluidics
Crispr
Gene Silencing
Eric Verschuren Summary
Eric Verschuren, based in Netherlands, is currently a Clinical Medical Manager at Novo Nordisk. Eric Verschuren brings experience from previous roles at Novo Nordisk, Hybridize Therapeutics, Galapagos and GenDx. Eric Verschuren holds a 2019 - 2019 Biobusiness Summerschool. With a robust skill set that includes Molecular Cloning, Immunohistochemistry, qPCR, Protein Purification, Western Blotting and more. Eric Verschuren has 2 emails on RocketReach.
Looking for a different Eric Verschuren?
Find contact details for 700 million professionals.